Organization
University College London, Centre for Rheumatology Research, London, United Kingdom
3 abstracts
Abstract
BILAG-2004 INDEX ACTIVE DISEASE PREDICTS DEVELOPMENT OF DAMAGEOrg: Doncaster & Bassetlaw Teaching Hospitals NHS Foundation Trust, Department of Rheumatology, Doncaster, United Kingdom, University of Cambridge, MRC Biostatistics Unit, Cambridge, United Kingdom, Sheffield Teaching Hospitals NHS Foundation Trust, Department of Rheumatology, Sheffield, United Kingdom, Nottingham University Hospitals NHS Trust, Department of Rheumatology, Nottingham, United Kingdom, University Hospital Southampton NHS Foundation Trust, Department of Rheumatology, Southampton, United Kingdom,
Abstract
BILAG-2004 LDA AND BST LDA ARE VALID TREAT TO TARGET IN SLEOrg: Doncaster & Bassetlaw Teaching Hospitals NHS Foundation Trust, Department of Rheumatology, Doncaster, United Kingdom, University of Birmingham, Rheumatology Research Group, Birmingham, United Kingdom, Sheffield Teaching Hospitals NHS Foundation Trust, Department of Rheumatology, Sheffield, United Kingdom, Nottingham University Hospitals NHS Trust, Department of Rheumatology, Nottingham, United Kingdom, University Hospital Southampton NHS Foundation Trust, Department of Rheumatology, Southampton, United Kingdom,
Abstract
ANTIDRUG ANTIBODIES ARE NEGATIVELY ASSOCIATED WITH RESPONSE TO BIOLOGICAL DRUGS IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS OF THE ABIRISK STUDYOrg: Université Paris-Saclay, INSERM U1184, Hôpitaux Universitaires Paris Saclay, APHP, FHU CARE, Rheumatology, Le Kremin Bicêtre, France, INSERM U1018, Université Paris Saclay, CESP, Villejuif, France, University of Tours, CNRS 7292, Tours, France, Faculty of Pharmacy, Paris-Saclay University, INSERM UMR 996, Orsay, France, Hôpital Bicêtre AP-HP, Université Paris Saclay, Laboratoire d’immunolgie, Le Kremin Bicêtre, France,